Chen Bihua

(See below) at GreenLight Biosciences Holdings, PBC · on record since Jun 8, 2023
10% owner at EyePoint, Inc. · on record since Dec 12, 2023
10% owner at Corbus Pharmaceuticals Holdings, Inc. · on record since Jan 30, 2024
Director at BridgeBio Oncology Therapeutics, Inc. · on record since Feb 13, 2024
CEO and Chairperson at BridgeBio Oncology Therapeutics, Inc. · on record since Feb 13, 2024
10% owner at BridgeBio Oncology Therapeutics, Inc. · on record since Feb 13, 2024
10% owner at BioAge Labs, Inc. · on record since Sep 25, 2024
10% owner at DRAGON PHARMACEUTICAL INC · on record since Oct 17, 2024
10% owner at OnKure Therapeutics, Inc. · on record since Oct 15, 2024
Former 10% Owner at BioAge Labs, Inc. · on record since Oct 1, 2024
Former 10% Owner at Aardvark Therapeutics, Inc. · on record since Feb 19, 2025
10% owner at Aardvark Therapeutics, Inc. · on record since Feb 12, 2025
Former 10% Owner at OnKure Therapeutics, Inc. · on record since May 19, 2025
Former Director at Biomea Fusion, Inc. · on record since Aug 1, 2025
Former 10% Owner at EyePoint, Inc. · on record since Dec 8, 2025
Former 10% Owner at MoonLake Immunotherapeutics · on record since Oct 1, 2025
Director at Helix Acquisition Corp. III · on record since Jan 28, 2026
Chairperson and CEO at Helix Acquisition Corp. III · on record since Jan 28, 2026
10% owner at · on record since Jan 28, 2026
10% owner at · on record since Jun 24, 2021
Director at · on record since Jun 23, 2021
Director at · on record since Jun 23, 2021
10% owner at · on record since Sep 14, 2021
Director at · on record since Apr 22, 2021
10% owner at · on record since Apr 22, 2021
Former 10% Owner at · on record since Apr 30, 2026
10% owner at · on record since Apr 19, 2021
Director at · on record since Nov 23, 2016
10% owner at · on record since Nov 23, 2016
10% owner at · on record since Jun 16, 2021
Director at · on record since Sep 5, 2014
10% owner at · on record since Sep 5, 2014
Director at · on record since Jun 13, 2016
10% owner at · on record since Jun 13, 2016
Director at · on record since Aug 6, 2026
10% owner at · on record since Aug 6, 2026
Director at · on record since Nov 14, 2017
10% owner at · on record since Nov 14, 2017
Director at · on record since May 31, 2018
10% owner at · on record since May 31, 2018
Director at · on record since Jun 27, 2018
10% owner at · on record since Jun 27, 2018
Director at · on record since Jul 20, 2018
10% owner at · on record since Jul 20, 2018
Director at · on record since Oct 30, 2018
10% owner at · on record since Oct 30, 2018
Director at · on record since Apr 25, 2019
10% owner at · on record since Apr 25, 2019
Director at · on record since Jun 25, 2020
10% owner at · on record since Jun 25, 2020
Director at · on record since Jun 18, 2020
10% owner at · on record since Jun 18, 2020
10% owner at · on record since Jul 29, 2021
Director at · on record since Oct 29, 2020
10% owner at · on record since Oct 29, 2020
Director at · on record since Nov 23, 2020
10% owner at · on record since Nov 23, 2020
Director at · on record since Oct 22, 2020
CEO and Chairman at · on record since Oct 22, 2020
10% owner at · on record since Oct 22, 2020
Director at · on record since Dec 22, 2020
10% owner at · on record since Dec 22, 2020
Director at · on record since Mar 25, 2021
10% owner at · on record since Mar 25, 2021
Director at · on record since Mar 18, 2021
10% owner at · on record since Mar 18, 2021
10% owner at · on record since Jun 30, 2021
10% owner at · on record since Jun 29, 2021
Director at · on record since Apr 29, 2021
10% owner at · on record since Jul 28, 2021
Director at · on record since Jul 22, 2021
10% owner at · on record since Jul 16, 2021
Former 10% Owner at · on record since Jul 7, 2021
Former 10% Owner at · on record since Aug 4, 2021
Former 10% Owner at · on record since Oct 27, 2021
10% owner at · on record since Oct 20, 2021
10% owner at · on record since Oct 7, 2021
Former 10% Owner at · on record since Jan 13, 2022
10% owner at · on record since Jan 6, 2022
10% owner at · on record since Mar 16, 2023

Insider trading activity of Chen Bihua

Transactions on record: 131; since Nov 7, 2016

Open-market buys: 79; $301.5M

Open-market sells: 3; $4.1M

Companies traded: 18; last filing Aug 10, 2026

Figures computed from official regulatory filings — .

Companies where Chen Bihua has traded

6 tx · $5M · Aug 10, 2026
20 tx · $104.1M · Jul 6, 2026
3 tx · $13M · Jan 28, 2026
25 tx · $32.8M · Dec 15, 2025
2 tx · Jun 13, 2025
3 tx · $3M · Feb 19, 2025
3 tx · $8.1M · Oct 1, 2024
1 tx · Jul 24, 2023
36 tx · $110.1M · Jul 5, 2023
4 tx · $8.2M · Jun 26, 2023
3 tx · $59M · Apr 20, 2023
4 tx · $10M · Oct 27, 2021
3 tx · $4M · Jul 1, 2021
3 tx · $7.7M · Apr 29, 2021

Track record of Chen Bihua

Statistical track record

Free account

Open-market buys: 79

Last buy: Aug 10, 2026

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Chen Bihua

Co-insiders of Chen Bihua

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
BlossomHill Therapeutics, Inc.Listing unverified	Aug 10, 2026	Other	1,599,993	—	n/a (No price was disclosed in the filing)		SEC
BlossomHill Therapeutics, Inc.Listing unverified	Aug 10, 2026	OtherD (derivative)	-1,599,993	—	n/a (No price was disclosed in the filing)		SEC
BlossomHill Therapeutics, Inc.Listing unverified	Aug 10, 2026	Other	1,701,541	—	n/a (No price was disclosed in the filing)		SEC
BlossomHill Therapeutics, Inc.Listing unverified	Aug 10, 2026	AwardD (derivative)	23,904	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BlossomHill Therapeutics, Inc.Listing unverified	Aug 10, 2026	OtherD (derivative)	-1,701,541	—	n/a (No price was disclosed in the filing)		SEC
BlossomHill Therapeutics, Inc.Listing unverified	Aug 10, 2026	Buy	312,500	16.00 USD	$5M	conv 39Cluster	SEC
BridgeBio Oncology Therapeutics, Inc.Listing unverified	Jul 6, 2026	Other	1,704,862	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BridgeBio Oncology Therapeutics, Inc.Listing unverified	Jul 6, 2026	Other	-4,528,186	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BridgeBio Oncology Therapeutics, Inc.Listing unverified	Jul 6, 2026	Other	130,865	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BridgeBio Oncology Therapeutics, Inc.Listing unverified	Jul 6, 2026	Other	2,692,459	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BridgeBio Oncology Therapeutics, Inc.Listing unverified	Jun 18, 2026	AwardD (derivative)	31,675	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Helix Acquisition Corp. IIIListing unverified	Jan 28, 2026	Award	497,500	10.00 USD	$5M		SEC
Helix Acquisition Corp. IIIListing unverified	Jan 28, 2026	Buy	800,000	10.00 USD	$8M	conv 42	SEC
Helix Acquisition Corp. IIIListing unverified	Jan 28, 2026	OtherD (derivative)	718,750	—	n/a (No price was disclosed in the filing)		SEC
Corbus Pharmaceuticals Holdings, Inc.Listing on record	Dec 15, 2025	Sell	-30,029	11.46 USD	$344.1K		SEC
BridgeBio Oncology Therapeutics, Inc.Listing unverified	Aug 13, 2025	Award	1,762,760	—	n/a (No price was disclosed in the filing)		SEC
BridgeBio Oncology Therapeutics, Inc.Listing unverified	Aug 13, 2025	Award	639,110	10.72 USD	$6.9M	Unusual size	SEC
BridgeBio Oncology Therapeutics, Inc.Listing unverified	Aug 13, 2025	Exercise	4,172,126	—	n/a (No price was disclosed in the filing)		SEC
BridgeBio Oncology Therapeutics, Inc.Listing unverified	Aug 13, 2025	Award	760,496	10.72 USD	$8.2M	Unusual size	SEC
BridgeBio Oncology Therapeutics, Inc.Listing unverified	Aug 13, 2025	Award	284,571	—	n/a (No price was disclosed in the filing)		SEC
BridgeBio Oncology Therapeutics, Inc.Listing unverified	Aug 13, 2025	OtherD (derivative)	-307,874	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BridgeBio Oncology Therapeutics, Inc.Listing unverified	Aug 13, 2025	Award	5,598,425	10.72 USD	$60M	Unusual size	SEC
BridgeBio Oncology Therapeutics, Inc.Listing unverified	Aug 13, 2025	Other	-152,940	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BridgeBio Oncology Therapeutics, Inc.Listing unverified	Aug 13, 2025	Award	1,905,046	—	n/a (No price was disclosed in the filing)		SEC
BridgeBio Oncology Therapeutics, Inc.Listing unverified	Aug 13, 2025	ExerciseD (derivative)	-4,172,126	—	n/a (No price was disclosed in the filing)		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
BlossomHill Therapeutics, Inc.Listing unverified	Aug 10, 2026	Other	1,599,993	—	n/a (No price was disclosed in the filing)		SEC
BlossomHill Therapeutics, Inc.Listing unverified	Aug 10, 2026	OtherD (derivative)	-1,599,993	—	n/a (No price was disclosed in the filing)		SEC
BlossomHill Therapeutics, Inc.Listing unverified	Aug 10, 2026	Other	1,701,541	—	n/a (No price was disclosed in the filing)		SEC
BlossomHill Therapeutics, Inc.Listing unverified	Aug 10, 2026	AwardD (derivative)	23,904	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BlossomHill Therapeutics, Inc.Listing unverified	Aug 10, 2026	OtherD (derivative)	-1,701,541	—	n/a (No price was disclosed in the filing)		SEC
BlossomHill Therapeutics, Inc.Listing unverified	Aug 10, 2026	Buy	312,500	16.00 USD	$5M	conv 39Cluster	SEC
BridgeBio Oncology Therapeutics, Inc.Listing unverified	Jul 6, 2026	Other	1,704,862	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BridgeBio Oncology Therapeutics, Inc.Listing unverified	Jul 6, 2026	Other	-4,528,186	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BridgeBio Oncology Therapeutics, Inc.Listing unverified	Jul 6, 2026	Other	130,865	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BridgeBio Oncology Therapeutics, Inc.Listing unverified	Jul 6, 2026	Other	2,692,459	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BridgeBio Oncology Therapeutics, Inc.Listing unverified	Jun 18, 2026	AwardD (derivative)	31,675	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Helix Acquisition Corp. IIIListing unverified	Jan 28, 2026	Award	497,500	10.00 USD	$5M		SEC
Helix Acquisition Corp. IIIListing unverified	Jan 28, 2026	Buy	800,000	10.00 USD	$8M	conv 42	SEC
Helix Acquisition Corp. IIIListing unverified	Jan 28, 2026	OtherD (derivative)	718,750	—	n/a (No price was disclosed in the filing)		SEC
Corbus Pharmaceuticals Holdings, Inc.Listing on record	Dec 15, 2025	Sell	-30,029	11.46 USD	$344.1K		SEC
BridgeBio Oncology Therapeutics, Inc.Listing unverified	Aug 13, 2025	Award	1,762,760	—	n/a (No price was disclosed in the filing)		SEC
BridgeBio Oncology Therapeutics, Inc.Listing unverified	Aug 13, 2025	Award	639,110	10.72 USD	$6.9M	Unusual size	SEC
BridgeBio Oncology Therapeutics, Inc.Listing unverified	Aug 13, 2025	Exercise	4,172,126	—	n/a (No price was disclosed in the filing)		SEC
BridgeBio Oncology Therapeutics, Inc.Listing unverified	Aug 13, 2025	Award	760,496	10.72 USD	$8.2M	Unusual size	SEC
BridgeBio Oncology Therapeutics, Inc.Listing unverified	Aug 13, 2025	Award	284,571	—	n/a (No price was disclosed in the filing)		SEC
BridgeBio Oncology Therapeutics, Inc.Listing unverified	Aug 13, 2025	OtherD (derivative)	-307,874	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BridgeBio Oncology Therapeutics, Inc.Listing unverified	Aug 13, 2025	Award	5,598,425	10.72 USD	$60M	Unusual size	SEC
BridgeBio Oncology Therapeutics, Inc.Listing unverified	Aug 13, 2025	Other	-152,940	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
BridgeBio Oncology Therapeutics, Inc.Listing unverified	Aug 13, 2025	Award	1,905,046	—	n/a (No price was disclosed in the filing)		SEC
BridgeBio Oncology Therapeutics, Inc.Listing unverified	Aug 13, 2025	ExerciseD (derivative)	-4,172,126	—	n/a (No price was disclosed in the filing)		SEC